Postoperative Energy and Protein Intake Attainment After Elective Laparoscopic Colorectal Cancer Surgery
NCT07931716, Not yet recruiting, First Affiliated Hospital of Chongqing Medical University
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Postoperative Energy and Protein Intake Attainment After Elective Laparoscopic Colorectal Cancer Surgery | ClinicalTrials.gov |
| NCT number | NCT07931716 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 360 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | First Affiliated Hospital of Chongqing Medical University | ClinicalTrials.gov |
| Conditions | Postoperative Gastrointestinal Dysfunction, Feeding Intolerance, Colorectal Cancer | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Proportion of patients reaching at least 60% of the prescribed energy target | Postoperative day 5, or day of discharge if earlier (assessed up to 7 days after surgery) | ClinicalTrials.gov | |
| Secondary | Daily energy intake as a percentage of the prescribed target, target set at 25 kcal/kg/day | Postoperative day 1 to Postoperative day 7 | ClinicalTrials.gov | |
| Secondary | Daily protein intake as a percentage of the prescribed target, target set at 1.5 g/kg/day | Postoperative day 1 to Postoperative day 7 | ClinicalTrials.gov | |
| Secondary | Time to first oral fluid, first flatus and first bowel movement | From end of surgery until first documented oral fluid, first flatus and first bowel movement, assessed up to 7 days after surgery | ClinicalTrials.gov | |
| Secondary | Time out of bed per postoperative day (hours) | From postoperative day 1, assessed daily up to postoperative day 7 | Time out of bed was recorded as the total number of hours per postoperative day during which the patient was out of bed, including sitting out of bed, standing and walking. | ClinicalTrials.gov |
| Secondary | Duration of supplemental or total parenteral nutrition in days | Postoperative day 1 to the day of discharge (assessed up to 30 days after surgery) | ClinicalTrials.gov | |
| Secondary | I-FEED(Intake, Feeling nauseated, Emesis, Exam, Duration) score | Postoperative day 1 to Postoperative day 7 | The I-FEED is a five-domain composite instrument for postoperative gastrointestinal dysfunction. Intake, feeling nauseated, emesis and abdominal examination are each scored 0, 1 or 3; duration of symptoms is scored 0, 1 or 2. The total score ranges from 0 to 14, with higher scores indicating worse gastrointestinal function | ClinicalTrials.gov |
| Secondary | Patient-level and clinician-level barriers to adequate intake | Postoperative day 1 to Postoperative day 7 | ClinicalTrials.gov | |
| Secondary | Postoperative serum albumin | Postoperative day 1 to Postoperative day 7 | ClinicalTrials.gov | |
| Secondary | Gastrointestinal-2 recovery | Postoperative day 1 to Postoperative day 7 | GI-2 is a composite endpoint defined as the later of two events: first tolerance of a semi-liquid diet and first passage of a bowel movement after surgery. | ClinicalTrials.gov |
| Secondary | length of stay | Postoperative day 1 to the day of discharge (assessed up to 30 days after surgery) | ClinicalTrials.gov | |
| Secondary | 30-day complications and readmission | Postoperative day 1 to Postoperative day 30 (assessed up to 30 days after surgery) | ClinicalTrials.gov | |
| Secondary | Interval from surgery to initiation of the first postoperative anti-tumour therapy | From date of surgery to initiation of first postoperative anti-tumour therapy, assessed up to 3 months after surgery(assessed up to 14 weeks after surgery) | Telephone follow-up at 3 months after surgery with a 2-week window | ClinicalTrials.gov |
| Secondary | percentage of body weight lost at 3 months | From admission to 3 months after surgery (assessed up to 14 weeks after surgery) | Percentage of body weight lost at 3 months after surgery, calculated as (body weight at admission minus body weight at 3 months after surgery) divided by body weight at admission, multiplied by 100. Admission body weight was measured on the ward before surgery and recorded in the medical record. Body weight at 3 months was obtained at the routine postoperative follow-up visit, with a permitted window of 2 weeks either side of the 3-month time point. Where the patient could not attend, weight was obtained by telephone from a household scale or from the local clinic record. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)